Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 12 October, 2018

Euronext Dublin

GEM Notice

RNS Number : 9514D
Euronext Dublin
12 October 2018
 

 

EURONEXT DUBLIN

 

 

 

 

ADMISSION NOTICE

 

                                   

Euronext Dublin

28 Anglesea Street

Dublin 2

 

 

12th October 2018

 

Euronext Dublin approves the admission of the undermentioned securities to listing on the Official List and trading on the Global Exchange Market.

 

 

KKR CLO 12 LTD  and KKR CLO 12 LLC

 

Class X Senior Secured Floating Rate Notes due 2030 (144A) US48250RBC97

Class X Senior Secured Floating Rate Notes due 2030 (Reg S) USG5277VAN94

Class D-R2 Senior Secured Deferrable Floating Rate Notes due 2030 (Reg S) USG5277VAS81

Class A-R2b Senior Secured Floating Rate Notes due 2030 (144A) US48250RBG02

Class C-R2 Senior Secured Deferrable Floating Rate Notes due 2030 (Reg S) USG5277VAR09

Class A-R2a Senior Secured Floating Rate Notes due 2030 (Reg S) USG5277VAP43

Class B-R2 Senior Secured Floating Rate Notes due 2030 (Reg S) USG5277VAT64

Class B-R2 Senior Secured Floating Rate Notes due 2030 (144A) US48250RBN52

Class C-R2 Senior Secured Deferrable Floating Rate Notes due 2030 (144A) US48250RBJ41

Class E-R2 Senior Secured Deferrable Floating Rate Notes due 2030 (144A) US48250QAH11

Class A-R2a Senior Secured Floating Rate Notes due 2030 (144A) US48250RBE53

Class A-R2b Senior Secured Floating Rate Notes due 2030 (Reg S) USG5277VAQ26

Class E-R2 Senior Secured Deferrable Floating Rate Notes due 2030 (Reg S) USG5277UAD30

Class D-R2 Senior Secured Deferrable Floating Rate Notes due 2030 (144A) US48250RBL96

 

Debt Security

 

This announcement has been issued through the Companies Announcement Service of

Euronext Dublin.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEELLFFVBFXFBZ

a d v e r t i s e m e n t